CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C14204 | BRD-K37150847 | BRD-K37150847 | -- | -- | -- | Details |
| C14205 | BRD-K37151368 | adaptavir | -- | -- | -- | Details |
| C14206 | BRD-K37151525 | BRD-K37151525 | -- | -- | -- | Details |
| C14207 | BRD-K37160016 | BRD-K37160016 | -- | -- | -- | Details |
| C14208 | BRD-K37160541 | BRD-K37160541 | -- | -- | -- | Details |
| C14209 | BRD-K37161540 | BRD-K37161540 | -- | -- | -- | Details |
| C14210 | BRD-K37165790 | BRD-K37165790 | -- | -- | -- | Details |
| C14211 | BRD-K37167897 | BRD-K37167897 | -- | -- | -- | Details |
| C14212 | BRD-K37168393 | BRD-K37168393 | -- | -- | -- | Details |
| C14213 | BRD-K37174007 | BRD-K37174007 | -- | -- | -- | Details |
| C14214 | BRD-K37174896 | BRD-K37174896 | -- | -- | -- | Details |
| C14215 | BRD-K37176385 | BRD-K37176385 | -- | -- | -- | Details |
| C14216 | BRD-K37184875 | BRD-K37184875 | -- | -- | -- | Details |
| C14217 | BRD-K37185609 | BRD-K37185609 | -- | -- | -- | Details |
| C14218 | BRD-K37187815 | cefuroxime | -- | -- | -- | Details |
| C14219 | BRD-K37194137 | III606050 | -- | -- | III-606050 | Details |
| C14220 | BRD-K37197256 | BRD-K37197256 | -- | -- | -- | Details |
| C14221 | BRD-K37203382 | BRD-K37203382 | -- | -- | -- | Details |
| C14222 | BRD-K37203945 | BRD-K37203945 | -- | -- | -- | Details |
| C14223 | BRD-K37206356 | rhamnetin | ALOX5 | Aldose reductase inhibitor | -- | Details |
| C14224 | BRD-K37208476 | ethisterone | -- | -- | -- | Details |
| C14225 | BRD-K37213205 | BRD-K37213205 | -- | -- | -- | Details |
| C14226 | BRD-K37219127 | BRD-K37219127 | -- | -- | -- | Details |
| C14227 | BRD-K37219781 | BRD-K37219781 | -- | -- | -- | Details |
| C14228 | BRD-K37225168 | BRD-K37225168 | -- | -- | -- | Details |
| C14229 | BRD-K37225211 | BRD-K37225211 | -- | -- | -- | Details |
| C14230 | BRD-K37226311 | BRD-K37226311 | -- | -- | -- | Details |
| C14231 | BRD-K37226353 | BRD-K37226353 | -- | -- | -- | Details |
| C14232 | BRD-K37231045 | BRD-K37231045 | -- | -- | -- | Details |
| C14233 | BRD-K37237504 | CEP-33779 | JAK2 | JAK inhibitor | -- | Details |
| C14234 | BRD-K37237818 | BRD-K37237818 | -- | -- | -- | Details |
| C14235 | BRD-K37246443 | BRD-K37246443 | -- | -- | -- | Details |
| C14236 | BRD-K37249103 | BRD-K37249103 | -- | -- | -- | Details |
| C14237 | BRD-K37249724 | astemizole | HRH1; KCNH2 | Histamine receptor antagonist | -- | Details |
| C14238 | BRD-K37251488 | BRD-K37251488 | -- | -- | -- | Details |
| C14239 | BRD-K37252182 | BRD-K37252182 | -- | -- | -- | Details |
| C14240 | BRD-K37253893 | BRD-K37253893 | -- | -- | -- | Details |
| C14241 | BRD-K37253987 | BRD-K37253987 | -- | -- | -- | Details |
| C14242 | BRD-K37254228 | BRD-K37254228 | -- | -- | -- | Details |
| C14243 | BRD-K37255594 | BRD-K37255594 | -- | -- | -- | Details |
| C14244 | BRD-K37262314 | BRD-K37262314 | -- | -- | -- | Details |
| C14245 | BRD-K37262603 | BRD-K37262603 | -- | -- | -- | Details |
| C14246 | BRD-K37262906 | BRD-K37262906 | -- | -- | -- | Details |
| C14247 | BRD-K37264083 | levisoprenaline | -- | -- | -- | Details |
| C14248 | BRD-K37268490 | BRD-K37268490 | -- | -- | -- | Details |
| C14249 | BRD-K37269981 | BRD-K37269981 | -- | -- | -- | Details |
| C14250 | BRD-K37270826 | mifepristone | NR3C1; AR; PGR | Progesterone receptor antagonist; Glucocorticoid receptor antagonist | -- | Details |
| C14251 | BRD-K37271110 | BRD-K37271110 | -- | -- | -- | Details |
| C14252 | BRD-K37273423 | BRD-K37273423 | -- | -- | -- | Details |
| C14253 | BRD-K37276417 | BRD-K37276417 | -- | -- | -- | Details |
| C14254 | BRD-K37277634 | BRD-K37277634 | -- | -- | -- | Details |
| C14255 | BRD-K37277666 | BRD-K37277666 | -- | -- | -- | Details |
| C14256 | BRD-K37280550 | BRD-K37280550 | -- | -- | -- | Details |
| C14257 | BRD-K37282009 | BRD-K37282009 | -- | -- | -- | Details |
| C14258 | BRD-K37282474 | BRD-K37282474 | -- | -- | -- | Details |
| C14259 | BRD-K37283718 | BRD-K37283718 | -- | -- | -- | Details |
| C14260 | BRD-K37284732 | BRD-K37284732 | -- | -- | -- | Details |
| C14261 | BRD-K37285826 | BRD-K37285826 | -- | -- | -- | Details |
| C14262 | BRD-K37289225 | clozapine | CHRM1; CHRM2; CHRM3; CHRM4; ADRA1B; ADRA1A; DRD1; DRD2; DRD3; DRD4; HRH1; HTR1A; HTR1B; HTR1D; HTR1E; HTR2A; HTR2C; HTR6; HTR7; HRH4 | Dopamine receptor antagonist; Serotonin receptor antagonist | -- | Details |
| C14263 | BRD-K37290471 | BRD-K37290471 | -- | -- | -- | Details |
| C14264 | BRD-K37290968 | BRD-K37290968 | -- | -- | -- | Details |
| C14265 | BRD-K37291743 | BRD-K37291743 | -- | -- | -- | Details |
| C14266 | BRD-K37299375 | BRD-K37299375 | -- | -- | -- | Details |
| C14267 | BRD-K37300049 | BRD-K37300049 | -- | -- | -- | Details |
| C14268 | BRD-K37303684 | BRD-K37303684 | -- | -- | -- | Details |
| C14269 | BRD-K37304120 | BRD-K37304120 | -- | -- | -- | Details |
| C14270 | BRD-K37306329 | BRD-K37306329 | -- | -- | -- | Details |
| C14271 | BRD-K37306336 | BRD-K37306336 | -- | -- | -- | Details |
| C14272 | BRD-K37308886 | BRD-K37308886 | -- | -- | -- | Details |
| C14273 | BRD-K37312348 | kenpaullone | CDK5; GSK3B; CDK1 | CDK inhibitor; GSK-3 inhibitor | -- | Details |
| C14274 | BRD-K37315860 | BRD-K37315860 | -- | -- | -- | Details |
| C14275 | BRD-K37316418 | BRD-K37316418 | -- | -- | -- | Details |
| C14276 | BRD-K37316675 | BRD-K37316675 | -- | -- | -- | Details |
| C14277 | BRD-K37317589 | BRD-K37317589 | -- | -- | -- | Details |
| C14278 | BRD-K37322457 | BRD-K37322457 | -- | -- | -- | Details |
| C14279 | BRD-K37323001 | BRD-K37323001 | -- | -- | -- | Details |
| C14280 | BRD-K37324401 | BRD-K37324401 | -- | -- | -- | Details |
| C14281 | BRD-K37328981 | BRD-K37328981 | -- | -- | -- | Details |
| C14282 | BRD-K37331547 | BRD-K37331547 | -- | -- | -- | Details |
| C14283 | BRD-K37336973 | BRD-K37336973 | -- | -- | -- | Details |
| C14284 | BRD-K37340147 | BRD-K37340147 | -- | -- | -- | Details |
| C14285 | BRD-K37340241 | BRD-K37340241 | -- | -- | -- | Details |
| C14286 | BRD-K37344040 | BRD-K37344040 | -- | -- | -- | Details |
| C14287 | BRD-K37355418 | efaproxiral | -- | -- | -- | Details |
| C14288 | BRD-K37356599 | BRD-K37356599 | -- | -- | -- | Details |
| C14289 | BRD-K37357048 | BRD-K37357048 | -- | -- | -- | Details |
| C14290 | BRD-K37357652 | BRD-K37357652 | -- | -- | -- | Details |
| C14291 | BRD-K37365015 | BRD-K37365015 | -- | -- | -- | Details |
| C14292 | BRD-K37369665 | BRD-K37369665 | -- | -- | -- | Details |
| C14293 | BRD-K37372998 | BRD-K37372998 | -- | -- | -- | Details |
| C14294 | BRD-K37379014 | filanesib | KIF11 | Kinesin inhibitor | -- | Details |
| C14295 | BRD-K37379978 | BRD-K37379978 | -- | -- | -- | Details |
| C14296 | BRD-K37385792 | conivaptan | AVPR1A; AVPR2 | Vasopressin receptor antagonist | -- | Details |
| C14297 | BRD-K37386363 | BRD-K37386363 | -- | -- | -- | Details |
| C14298 | BRD-K37387086 | BRD-K37387086 | -- | -- | -- | Details |
| C14299 | BRD-K37390332 | BRD-K37390332 | -- | -- | -- | Details |
| C14300 | BRD-K37392901 | NSC-632839 | SENP2; USP1; USP7; USP2 | Ubiquitin specific protease inhibitor | -- | Details |
| C14301 | BRD-K37393297 | BRD-K37393297 | -- | -- | -- | Details |
| C14302 | BRD-K37398676 | BRD-K37398676 | -- | -- | -- | Details |
| C14303 | BRD-K37398853 | BRD-K37398853 | -- | -- | -- | Details |